NEW—Radiotherapy following prostate cancer surgery can safely be avoided for many men: finding from a prospectively planned systematic review & meta-analysis assessing results from 2153 men enrolled across 3 trials, with median follow-up of at least 5 yrs hubs.li/H0x3LxP0
NEW—Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial hubs.li/H0x5PXH0 (Trial 1/3)
NEW—Adjuvant radiotherapy vs early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial @TheLancetOncol (Trial 2/3) hubs.li/H0x69kT0
NEW—Adjuvant radiotherapy vs early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial @TheLancetOncol (Trial 3/3) hubs.li/H0x6rpS0
NEW—Timing of radiotherapy after radical prostatectomy
"The studies did not show superiority of adjuvant radiotherapy compared with salvage radiotherapy based on the early endpoint of progression-free survival"
‘Policy inertia’ is enabling the products and practices of some commercial actors to cause significant, ongoing harm to health, warn experts.
A new Lancet Series argues for a bold system overhaul that puts people and planet first: hubs.li/Q01HD8h_0
What are the commercial determinants of health?
Lack of consensus on the definition has been a sticking point, hampering action.
The Series authors provide an explanation and outline potential pathways to health benefits or harms: hubs.li/Q01J2gbV0
While commercial actors can contribute positively to health and society, a significant proportion are not.
Just 4 industry sectors are responsible for at least 1/3 of global deaths every year:
🚬 Tobacco
🍺 Alcohol
🍔 Unhealthy foods
🏭 Fossil fuels hubs.li/Q01J2gbV0
New Lancet Commission details "massive global failures" of the #COVID19 response & issues recommendations to help:
1️⃣ End the pandemic emergency
2️⃣ Protect against future health shocks
3️⃣ Achieve sustainable development for all
Access the report: hubs.li/Q01mlD0h0
Glaring deficiencies in pandemic preparedness & response have cost lives, livelihoods, & progress towards the #SDGs.
The Lancet COVID-19 Commission identifies several failures of governance ⤵ hubs.li/Q01mmNZd0
Synthesising evidence from the first 2 years of #COVID19, Commission authors make 11 essential recommendations for a resilient post-pandemic world 👇 hubs.li/Q01mmNZd0
📢 The Lancet Group is pleased to announce an important step towards advancing equity, diversity, & inclusion in our publishing practices:
Authors & reviewers will now be invited to (optionally) self-report their gender, race, & ethnicity via our Editorial Manager sites. 1/4
Understanding the demographics of our authors & reviewers is integral to the work of the Lancet Group for Racial Equity (GRacE) & the Gender & Diversity Taskforce; to identify gaps in representation & propose solutions to address them. 2/4
This approach has already proven successful for gender data collection; we hope to build on this with the introduction of the schema & the addition of race & ethnicity as categories. 3/4
When successfully delivered, primary health care can:
1⃣ Improve equity, promote good health, & reduce risk of disease
2⃣ Limit the financial burden of health-care for households
3⃣ Save governments money
Although a staple of high-performing health systems, #PrimaryHealthCare lacks funding, quality, & accessibility in many low- & middle-income countries (LMICs).